Aggregated real-world outcome data collected from thousands of Medtronic MiniMed 670G users indicate that patients on the system spend an average 71% of their time within an optimal glycemic range.
Children with Type 1 diabetes will now have access to the Medtronic MiniMed 670G, a hybrid closed-loop system insulin delivery system, following the FDA’s decision to expand the product approval for a ...
The Food and Drug Administration's approval of a new insulin delivery system for people with Type 1 diabetes is a big deal. With Type 1 diabetes, the pancreas makes little or no insulin so people have ...
Medtronic plc.'s MDT Diabetes Management segment is dominating the headlines of late. Following the company’s receipt of the CE Mark approval for its advanced continuous glucose monitoring (CGM) ...
The U.S. Food and Drug Administration today approved Medtronic's MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and ...
William Blair on Tuesday initiated coverage on MiniMed Group Inc. MMED, a pure-play diabetes devices company. MiniMed's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results